Korea United Pharm Inc.
033270.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
217
Cost of Revenue
94
Gross Profit
123
Gross Margin
56.8%
Operating Income
42
Operating Margin
19.5%
Net Income
24
Net Margin
11.2%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
43
EBITDA Margin
20.0%
2023
12/31/2023
Revenue
209
Cost of Revenue
90
Gross Profit
119
Gross Margin
57.0%
Operating Income
41
Operating Margin
19.7%
Net Income
36
Net Margin
17.3%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
53
EBITDA Margin
25.4%
2022
12/31/2022
Revenue
197
Cost of Revenue
88
Gross Profit
109
Gross Margin
55.3%
Operating Income
36
Operating Margin
18.4%
Net Income
34
Net Margin
17.2%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
46
EBITDA Margin
23.5%
2021
12/31/2021
Revenue
166
Cost of Revenue
74
Gross Profit
92
Gross Margin
55.5%
Operating Income
25
Operating Margin
15.0%
Net Income
21
Net Margin
13.0%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
35
EBITDA Margin
21.1%
2020
12/31/2020
Revenue
162
Cost of Revenue
68
Gross Profit
94
Gross Margin
58.0%
Operating Income
30
Operating Margin
18.6%
Net Income
20
Net Margin
12.3%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
32
EBITDA Margin
20.0%